Search

everythinglearnresearchcommunity

for

Search:↓

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

A new engineered treatment shows promise in curing heart fibrosis.

Stem cell and plant exosomes may help heal and regenerate skin.

Non-drug therapies show promise for hair regrowth but need more research.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Cathepsin L deficiency causes hair and skin issues in mice.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.